| Both sides previous revisionPrevious revisionNext revision | Previous revisionBoth sides next revision |
university_of_alberta [2022/10/26 22:22]
liam | university_of_alberta [2022/10/26 22:55] (current)
liam [Metabolic and Cardiovascular Diseases Laboratory] |
|---|
| U of A received a $46,585 CAD grant in July 2021 from the [[Government of Canada]] for a project titled "WISEST: Building Confidence in Vaccines in Girls and Young Women in Canada."((//Encouraging vaccine confidence in Canada - Competition Results.// (2021, July 26). Natural Sciences and Engineering Research Council of Canada (NSERC). Retrieved November 3, 2021, from https://archive.ph/Zo5b5)) It was awarded through a grant program called //"Encouraging Vaccine Confidence in Canada"// jointly administered by the [[Canadian Institutes of Health Research]] (CIHR), [[Natural Sciences and Engineering Research Council]] (NSERC) and the [[Social Sciences and Humanities Research Council]] (SSHRC).((//Encouraging vaccine confidence in Canada.// (2021, July 26). Natural Sciences and Engineering Research Council of Canada. Retrieved November 3, 2021, from https://www.nserc-crsng.gc.ca/Promoter-Promotion/VaccineConfidence_eng.asp)) | U of A received a $46,585 CAD grant in July 2021 from the [[Government of Canada]] for a project titled "WISEST: Building Confidence in Vaccines in Girls and Young Women in Canada."((//Encouraging vaccine confidence in Canada - Competition Results.// (2021, July 26). Natural Sciences and Engineering Research Council of Canada (NSERC). Retrieved November 3, 2021, from https://archive.ph/Zo5b5)) It was awarded through a grant program called //"Encouraging Vaccine Confidence in Canada"// jointly administered by the [[Canadian Institutes of Health Research]] (CIHR), [[Natural Sciences and Engineering Research Council]] (NSERC) and the [[Social Sciences and Humanities Research Council]] (SSHRC).((//Encouraging vaccine confidence in Canada.// (2021, July 26). Natural Sciences and Engineering Research Council of Canada. Retrieved November 3, 2021, from https://www.nserc-crsng.gc.ca/Promoter-Promotion/VaccineConfidence_eng.asp)) |
| |
| In March 2022, the University announced the creation of the Pfizer Applied Clinical Pharmacology Program under the Faculty of Pharmacy and Pharmaceutical Sciences. The new program is in partnership with [[pharmaceutical_companies:Pfizer]] and [[Applied Pharmaceutical Innovation]] (API).((//Pfizer, Applied Pharmaceutical Innovation and University of Alberta launch the Pfizer Applied Clinical Pharmacology Program.// (2022, March 16). Applied Pharmaceutical Innovation. https://appliedpharma.ca/pfizer-applied-pharmaceutical-innovation-and-university-of-alberta-launch-the-pfizer-applied-clinical-pharmacology-program/)) | In March 2022, the University announced the creation of the Pfizer Applied Clinical Pharmacology Program under the Faculty of Pharmacy and Pharmaceutical Sciences. The new program is in partnership with [[pharmaceutical_companies:Pfizer]] and [[Applied Pharmaceutical Innovation]] (API).((//Pfizer, Applied Pharmaceutical Innovation and University of Alberta launch the Pfizer Applied Clinical Pharmacology Program.// (2022, March 16). Applied Pharmaceutical Innovation. https://web.archive.org/web/20221026202112/https://appliedpharma.ca/pfizer-applied-pharmaceutical-innovation-and-university-of-alberta-launch-the-pfizer-applied-clinical-pharmacology-program/)) |
| | |
| | ===== Organization ===== |
| | |
| | ==== Metabolic and Cardiovascular Diseases Laboratory ==== |
| | |
| | U of A's MCDL has previously received research funding from:((//Previous Funding Partners.// Metabolic and Cardiovascular Diseases Laboratory. Retrieved October 26, 2022, from https://web.archive.org/web/20221026204817/https://mcvd.ualberta.ca/research/previous-funding-partners/)) |
| | |
| | <WRAP column col4> |
| | * [[Advanced Foods and Materials Network]] (AFMNet) |
| | * [[Alberta Advanced Education and Technology]] |
| | * [[Alberta Diabetes Institute]] (ADI) |
| | * [[Alberta Health Services]] (AHS) |
| | * [[Alberta Innovates]] |
| | * [[Alberta Livestock and Meat Agency]] (ALMA) |
| | * [[American Society of Parenteral & Enteral Nutrition]] |
| | * [[Beef Information Centre]] (BIC) |
| | * [[Canada Foundation for Innovation]] (CFI) |
| | * [[Canadian Institutes of Health Research]] (CIHR) |
| | * [[Canadian Lipoprotein Conference]] |
| | * [[Ceapro]] |
| | * [[Dairy Farmers of Canada]] |
| | * [[Heart and Stroke Foundation of Canada]] |
| | * [[International Atherosclerosis Society]] |
| | * [[International Life Sciences Institute]] |
| | * [[pharmaceutical_companies:Johnson & Johnson]] |
| | * [[Mazankowski Alberta Hearth Institute]] |
| | * [[pharmaceutical_companies:Merck]] |
| | * [[MITACS]] |
| | * [[National Research Council Canada]] (NRC) |
| | * [[Natural Sciences and Engineering Research Council]] (NSERC) |
| | * [[Networks of Centres of Excellence of Canada]] |
| | * [[pharmaceutical_companies:Pfizer]] |
| | * [[pharmaceutical_companies:Sanofi-Aventis]] |
| | * [[Spanish Ministry of Science and Innovation]] |
| | * [[Stollery Children's Hospital Foundation]] |
| | * [[TEC Edmonton]] |
| | * [[University Hospital Foundation]] |
| | * [[Women's & Children's Health Research Institute]] |
| | </WRAP> |
